Related Experiment Video
Updated: Apr 15, 2026
07:30
Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
9.9K
The initial hyperglycemia in acute type II pyrethroid poisoning
Dongseob Kim1, Jeongmi Moon1, Byeongjo Chun1
1Department of Emergency Medicine, Chonnam National University Medical School, Gwangju, Korea.
Journal of Korean Medical Science
|April 2, 2015
Summary
Hyperglycemia at presentation can predict complications in non-diabetic patients with acute type II pyrethroid poisoning. This poisoning is not mild, with significant complication and mortality rates observed.
Area of Science:
- Toxicology
- Clinical Medicine
- Emergency Medicine
Background:
- Acute type II pyrethroid poisoning can lead to severe complications.
- The predictive factors for adverse outcomes in these patients require further investigation.
Purpose of the Study:
- To describe the clinical features of acute type II pyrethroid poisoning.
- To determine if hyperglycemia at presentation predicts outcomes in these patients.
Main Methods:
- Retrospective observational case series.
- Inclusion of 104 patients with type II pyrethroid poisoning.
- Analysis of clinical features, complications, and mortality rates.
Main Results:
- The complication and mortality rates were 26.9% and 2.9%, respectively.
- Respiratory failure was the most common complication.
- Hyperglycemia independently predicted complications in non-diabetic patients.
Conclusions:
- Type II pyrethroid poisoning is a serious condition.
- Hyperglycemia at presentation is a useful predictor of complications in non-diabetic patients.
- Diabetic patients experienced higher complication rates, but predictive factors were unclear.
Related Concept Videos
01:15Hypoglycemia and Glucagon
1.4K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.4K
01:26Anticholinesterase Agents: Poisoning and Treatment
2.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K
01:22Diabetes Mellitus: Type 2 and Gestational
5.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.9K
01:20Pathophysiology of Diabetes
4.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
01:26Pharmaceutical Poisoning: Treatment Strategies
217
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
217
01:22Diabetes Mellitus: Overview and Type I Subtype
6.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.4K